Cellino
Cambridge
About Cellino
Cellino is building an ultra-scalable biomanufacturing technology stack for personalized cell, tissue, and organ replacement therapies. Cellino’s vision is transform medicine to enhance healthspan for billions across generations.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $122.5M
- Funding stage: Early Stage Venture
- Last round: Grant (Sep 2024)
- Website: cellinobio.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/cellino-42310 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.